Want to see IN:PFIZER full AI Analyst Report?

PFIZER LIMITED (PFIZER) Earnings Dates, Call Summary & Reports

Q: What is the P/E ratio of PFIZER LIMITED stock?

The P/E ratio of {name} is N/A.

121 Followers

Earnings Data

Report Date

Aug 03, 2026

TBA (Confirmed)

Period Ending

2027 (Q1)

Consensus EPS Forecast

45.2

Last Year’s EPS

41.9

Same Quarter Last Year

Analyst Consensus

―

Based on 0 Analysts Ratings

Earnings Call Summary

Q2 2025

Earnings Call Date:Oct 28, 2024|

% Change Since:

Earnings Call Sentiment|Positive

Pfizer's earnings call reflected a strong financial performance with solid revenue and EPS growth, driven by effective cost management and advancements in the R&D pipeline. However, challenges such as impacts from the IRA Medicare Part D redesign and ongoing geopolitical uncertainties pose potential risks.

Company Guidance

During Pfizer's Second Quarter 2025 Earnings Conference Call, the company provided updated guidance reflecting strong year-to-date performance. Specifically, Pfizer raised its adjusted diluted EPS guidance for the full year 2025, driven by productivity gains and strategic initiatives to expand margins. The company reported second-quarter revenues of $14.7 billion, a 10% operational increase, and adjusted diluted EPS of $0.78, surpassing expectations. Pfizer's robust operating margins were achieved amidst challenges such as an $825 million unfavorable impact from higher manufacturer discounts due to the IRA Medicare Part D redesign. Pfizer's non-COVID portfolio, including strong performers like the Vyndaqel family and Eliquis, contributed significantly to its solid financial outlook. The company maintained its full-year 2025 revenue guidance of $61 billion to $64 billion and adjusted its SI&A and R&D expense forecasts while expecting an adjusted effective tax rate of approximately 13%. Pfizer's strategic focus remains on enhancing R&D productivity, leveraging AI and digital capabilities, and optimizing capital allocation to create long-term shareholder value.

Strong Revenue Growth

Pfizer recorded revenues of $14.7 billion for the second quarter, representing a 10% operational increase year-over-year.

Increased Earnings Guidance

Pfizer raised its adjusted diluted EPS guidance for the full year 2025 by $0.10, indicating strong performance and confidence in future results.

R&D Pipeline Advancements

Significant progress in the R&D pipeline with promising data for Elrexfio, SV, and Hympavzi, as well as the development of a C. diff vaccine.

Cost Management Success

Total adjusted operating expenses decreased by 8% operationally, demonstrating effective cost management strategies.

Strong Performance of Key Products

Products like Vyndaqel, Eliquis, and Padcev showed significant growth, with Vyndaqel growing 21% year-over-year operationally.

PFIZER LIMITED (IN:PFIZER) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

IN:PFIZER Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Play Transcript
Aug 03, 2026	2027 (Q1)	45.20 / -	41.9	―	―
May 12, 2026	2026 (Q4)	40.25 / 42.20	43	-1.86% (-0.80)	―
Feb 09, 2026	2026 (Q3)	36.60 / 40.40	27.9	44.80% (+12.50)	―
Nov 12, 2025	2026 (Q2)	42.60 / 41.30	34.6	19.36% (+6.70)	―
Aug 13, 2025	2026 (Q1)	34.70 / 41.90	32.9	27.36% (+9.00)	―
May 19, 2025	2025 (Q4)	35.85 / 43.00	39.1	9.97% (+3.90)	―
Jan 31, 2025	2025 (Q3)	31.80 / 27.90	27.1	2.95% (+0.80)	―
Oct 28, 2024	2025 (Q2)	37.00 / 34.60	32.6	6.13% (+2.00)	―
Jul 29, 2024	2025 (Q1)	- / 32.90	20.45	60.88% (+12.45)	―
May 29, 2024	2024 (Q4)	34.70 / 39.10	31.7	23.34% (+7.40)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

IN:PFIZER Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 12, 2026	₹4876.95	₹4728.90	-3.04%
Feb 09, 2026	₹4594.25	₹4760.60	+3.62%
Nov 12, 2025	₹4996.20	₹5020.05	+0.48%
Aug 13, 2025	₹5087.05	₹5125.80	+0.76%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does PFIZER LIMITED (IN:PFIZER) report earnings?

PFIZER LIMITED (IN:PFIZER) is schdueled to report earning on Aug 03, 2026, TBA (Confirmed).

What is PFIZER LIMITED (IN:PFIZER) earnings time?

PFIZER LIMITED (IN:PFIZER) earnings time is at Aug 03, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of PFIZER LIMITED stock?

The P/E ratio of PFIZER LIMITED is N/A.

What is IN:PFIZER EPS forecast?

IN:PFIZER EPS forecast for the fiscal quarter 2027 (Q1) is 45.2.